Trial intelligence / Profile preview

Pharmacokinetics of Amantadine and Ribavirin in Chronic Hepatitis C

NCT00199719Phase 2Completed

Sponsor
CHU de Limoges
Start
Jun 2003
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of ribavirin in hepatitis C (HCV), sponsored by CHU de Limoges. Started Jun 2003; status: completed.

02

Drugs

ribavirin
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00199719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00199719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call